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Implication for health policy/practice/research/medical education:
Oral administration of silymarin could ameliorate renal histopathological changes in paraquat-induced nephrotoxicity. Also, it 
reduced serum urea, creatinine, protein carbonyl, and malondialdehyde. Silymarin has anti-inflammatory, nephro-protective 
and anti-oxidative stress activities. Hence, it might be useful in patients who were exposed to nephrotoxic agents.
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Introduction: Paraquat is a quaternary nitrogen herbicide which induces kidney toxicity 
due to producing oxidative stress. We have investigated the potential protective effects of 
silymarin on paraquat-induced renal toxicity. 
Methods: Twenty-four male rats were divided into three groups, group 1, control group; 
group 2, rats that received paraquat only (25 mg/kg b.w./day, po); animals in group 3, was 
treated with paraquat (25 mg/kg b.w./day, po) and silymarin (50 mg/kg b.w./day, po). Then, 
the serum and tissue parameters of the oxidative stress and renal histopathological changes 
were examined.
Results: In group 2 which received paraquat only, a remarkable increase (P<0.05) was observed 
in serum creatinine, urea, malondialdehyde (MDA), protein carbonyl, and tumor necrosis 
factor alpha (TNF-α). Also, there was a significant decrease in renal superoxide dismutase, 
catalase (CAT), ferric reducing ability of plasma (FRAP) and vitamin C in the second group. 
Oral administration of silymarin significantly decreased serum urea, creatinine, protein 
carbonyl, MDA, and TNF-α as well as renal histopathological changes. 
Conclusion: The present study suggests that silymarin has anti-inflammatory and 
nephroprotective effects against nephrotoxicity caused by paraquat.
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Introduction
Paraquat is a very toxic herbicide used widely across 
the globe. Paraquat exerts its herbicide effects 
through interfering with the electron transfer system 
and inhibiting the conversion of nicotinamide 
adenine dinucleotide phosphate (NADP) to NADPH. 
This herbicide causes toxicity through production of 
anion superoxide (O2-), which can led to the production 
of other reactive oxygen species (ROS), such as radical 
hydroxyl (OH-) and hydrogen peroxide (H2O2) (1). 
Oxidative stress has key role in the toxicity of paraquat 
and leads to lipid peroxidation, body cell damage, and 
apoptosis (2). Paraquat is highly toxic for both humans 
and animals. It leads to some organ systems damage such 
as lung, liver, kidney, and Parkinson’s disease (PD), as well 
(3-5). Paraquat-induced renal toxicity is highly common 
and reported as the first systemic effects of the paraquat 
toxicity. A rapid increase in serum creatinine level have 
been observed in previous reports of paraquat toxicity, 
which was indicating a decrease in kidneys glomerular 
filtration rate (GFR). Paraquat causes impaired renal 
function which is  accompanied by reduction of the renal 
clearance rate and increasing of paraquat level, toxicity, 
and other organ dysfunctions (6,7). Administration of 
thioacetamide has been shown to induce liver and kidney 
injuries and silymarin ameliorated some parameters such 
as DNA fragmentation, nitric oxide, oxidative stress, 
collagen content, and liver and kidney histopathological 
changes in thioacetamide-induced toxicity (8). Silymarin 
is a potent antioxidant that can scavenge free radicals 
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and ROS (9). Silymarin is a flavonolignan containing 
a combination of silibinin, silydianin and silychristin, 
which is extracted from the seeds of Silybum marianum 
(10,11). This antioxidant compound is known as a safe 
and healthy herbal product (12). Silymarin is used in 
treatment of liver disorders, such as cirrhosis, chronic 
liver inflammation, and renal disorders (13,14). In this 
study, we’ve investigated the protective effects of silymarin 
on serum urea, creatinine (Cr), malondialdehyde (MDA), 
renal MDA, catalase (CAT), superoxide dismutase (SOD), 
vitamin C, and TNF-α gene expression in paraquat-
induced renal toxicity in rats.
Materials and Methods
Chemicals 
Paraquat (200 g/L paraquat dicholoride) was purchased 
from Shandong Luba Chemical Co. Ltd., Jinan, China. 
Urea and Cr kits were purchased from Pars Azmoon 
Co. (Tehran, Iran). Sodium acetate and thiobarbituric 
acid were provided from Merck (Darmstadt, Germany). 
Riboflavin, nitro blue tetrazolium, vitamin C were 
obtained from Sigma-Aldrich Co. (St. Louis, Mo USA). 
All other chemicals used were analytical grade.
Animal treatment and experimental design
Twenty-four male Wistar rats (10-12 weeks old, 180-
220 g), were divided into three groups (n=8/group). All 
animals were kept under normal laboratory conditions 
(22±2°C, 60±5% humidity, and 12:12 light dark cycle). 
Animals had access to standard rat pellet diet and water. 
The rats were divided randomly to three groups of 8 each, 
group 1 (Normal group) was orally given distilled water 
for 2 weeks. Group 2 (test group) was orally given paraquat 
only (25 mg/kg body weight/day) by gastric gavage for 2 
weeks (15). Group 3 was orally administered paraquat (25 
mg/kg body weight/day) and orally treated with silymarin 
(50 mg/kg body weight/day, po) (16) at an interval of 1 
hour for 2 weeks.
After 2 weeks, rats were anesthetized with chloroform 
and blood specimens collected by cardiac puncture method 
to separate serum and plasma. Also, kidney sample was 
removed to determine tumor necrosis factor-α (TNF-α) 
gene expression, kidney CAT, SOD, and histopathological 
examinations. 
Biochemical analysis
Urea and Cr were measured by enzymatic method with 
auto analyzer system (BT3000, Rome, Italy). Serum TNF-α 
was evaluated by enzyme-linked immune sorbent assay 
(ELISA) kit, (Bioassay technology laboratory Shanghai, 
China).
Serum and renal MDA levels were determined as 
described previously (17). Plasma antioxidant capacity 
was estimated by ferric reducing ability of plasma (FRAP) 
method as described previously (17). 
Renal CAT activity was measured by previously 
described method (18). The activity of the renal SOD 
was determined in the renal tissue by Beauchamp and 
Fridovich method (19) and total protein was determined 
by Bradford method (20).
Renal vitamin C level in the experimental groups was 
estimated by Stanley and Omaye method (21) and TNF-α 
gene expression was evaluated by real-time quantitative 
PCR (RT-qPCR) and the ΔΔCT method as described 
previously (22). β-actin was used as internal control for 
mRNA expression and normalizing data. The serum 
protein carbonyl level was assessed by Reznick and 
Parker’s spectrophotometric method (23). 
Kidney histopathological studies
Kidney sample in each rat fixed with formalin 20% for 
histopathological examination. After paraffin embedding, 
sections prepared at 5 μm thickness, stained by 
hematoxylin-eosin (H&E) (24), and histological changes 
were examined by optical microscope.
Statistical analysis
The results were expressed as mean ± SD. Analysis of the 
results was performed using one-way ANOVA by SPSS 
20.0 (SPSS Inc., Chicago, IL, USA), and Tukey’s post hoc 
test was used for multiple comparisons. Values of P < 0.05 
were considered significant.
Results
Effects of silymarin on serum urea, Cr, MDA, plasma 
FRAP and renal MDA levels
Table 1 shows the effects of paraquat and silymarin 
on serum urea, Cr, MDA and renal MDA levels in the 
experimental groups. Administration of paraquat in the 
second group (group receiving only paraquat) led to a 
significant elevation (P < 0.05) in serum urea, Cr, and 
MDA and renal MDA levels in comparison with the 
control group (Table 1). There was a remarkable reduction 
(P < 0.05) in serum urea, Cr, and MDA and renal MDA 
levels of the group treated with silymarin comparing with 
the second group (P < 0.05).
Group 2 has shown a significant reduction (P < 0.05) 
in FRAP level after receiving paraquat in comparison 
with the control group (Table 1). There was a significant 
increases (P < 0.05) in the plasma FRAP level of group 
which treated by silymarin when compared with the 
second group (group receiving only paraquat).
Effects of silymarin on renal CAT and SOD activities
Figure 1 shows that paraquat significantly decreased 
(P < 0.05) renal CAT and SOD activities compared with 
the control group. Oral administration of silymarin led 
to an increase (P < 0.05) in renal CAT and SOD activities 
compared to the second group (group receiving only 
paraquat). 
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Effects of silymarin on the renal vitamin C and PC levels
Figure 2 shows the effects of silymarin on the renal vitamin 
C and PC levels. Oral administration of paraquat in the 
second group led to a significant decrease (P < 0.05) in the 
renal vitamin C level compared to the control group. On 
the other hand, administration of silymarin has increased 
the renal vitamin C level significantly compared to the 
paraquat group (P < 0.05). Also, there was a significant 
increase (P < 0.05) in serum PC levels in rats receiving only 
paraquat when compared to the control group (Figure 2). 
Nevertheless, administration of silymarin has significantly 
reduced (P < 0.05) the serum PC level in comparison with 
the second group. 
Effects of silymarin on serum and renal TNF-α gene 
expression
Figure 3 shows the effects of silymarin on serum and renal 
TNF-α levels. In the second group (group receiving only 
Table 1. Effects of silymarin on serum urea, Cr, MDA, plasma FRAP and kidney MDA in paraquat-induced renal injury
Parameters Group 1 Group 2 Group 3
Cr (mg/dL) 0.42 ± 0.04 0.66 ± 0.05a 0.43 ± 0.05b
Urea (mg/dL) 45.37 ± 3.81 67.50 ± 2.07a 55.50 ± 3.33a,b
FRAP (µM) 518.38±36.14 393.13±29.06a 529.88±41.22b
Serum MDA (µM) 9.99±1.05 19.95±1.21a 11.13±0.94b
Kidney MDA (µmol/mg protein) 1.88±0.03 4.87±0.03a 2.50±0.03a,b
Abbreviatios: FRAP, ferric reducing ability of plasma; MDA, malondialdehyde; Cr, creatinine.
Values are expressed as mean ± SD. Group 1, normal control; group 2, receiving paraquat only; group 3, rats receiving paraquat and silymarin.
 aP < 0.05 compared to group 1.
bP < 0.05 compared to group 2.
Figure 1. Effects of silymarin on CAT and SOD activities. Values are expressed as mean ± SD and n=8 in each group. Group 1, normal control; 
group 2, received paraquat only; group 3, rats supplemented with paraquat and silymarin.
 aP < 0.05 compared to group 1.
bP < 0.05 compared to group 2.
Figure 2. Effects of silymarin on serum PC and vitamin C levels. Values are expressed as mean ± SD and n=8 in each group. Group 1, normal 
control; group 2, received paraquat only; group 3, rats supplemented with paraquat and silymarin.
aP < 0.05 compared to group 1.
bP < 0.05 compared to group 2.
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paraquat), administration of paraquat led to a significant 
increase (P < 0.05) in serum TNF-α levels and its renal gene 
expression than the control group. Oral administration 
of silymarin could significantly decrease (P < 0.05) serum 
and renal TNF-α gene expression compared to the second 
group (group receiving only paraquat) (Figure 3).
Histopathological findings
Microscopic studies of the second group (group receiving 
only paraquat) have shown lymphocyte infiltration 
compared to the control group (Figure 4). In the 
group treated with silymarin, a significant decrease in 
lymphocyte infiltration was seen compared to the second 
group (group receiving only paraquat). 
Discussion
Paraquat is secreted by proximal tubules before renal 
damage, but tubular damages happen with an increase 
in paraquat concentration. In paraquat-induced renal 
toxicity, primarily the glomerular coatings (podocytes) are 
damaged; then, tubular degeneration, and the formation 
of eosinophilic granular cytoplasm is happen in distal and 
proximal tubules (25-27). 
Paraquat-induced nephrotoxicity is a common causes of 
mortality in this group of patients (28). Urea and Cr are 
among the markers of renal toxicity workup (29). In this 
study, there is an increase in serum urea and Cr levels in 
group 2 (Table 1), which indicates the paraquat-induced 
renal damage; which was consistent with previous studies 
(27,29,30). In our study, administration of silymarin led 
to protect kidneys against paraquat toxicity and reduces 
serum urea and Cr levels (Table 1). According to previous 
reports, silymarin can reduce urea and Cr (10,13,31). 
Therefore, these effects of silymarin on paraquat-induced 
nephrotoxicity may be produced, at least in part, due to its 
antioxidant properties.
Paraquat toxicity caused by production of free radicals 
and oxidative agents (32). There are antioxidant systems 
against oxidative agents in human body. CAT and SOD are 
considered as enzymatic antioxidants (33). SOD converts 
superoxide anion into hydrogen peroxide; and CAT 
converts hydrogen peroxide into oxygen and water (34). 
In current study, the SOD and CAT levels were decreased 
(Figure 1), which is in accordance with previous studies 
that paraquat shown the ability to decrease the SOD and 
CAT level in kidney tissue (4). Nevertheless, in the present 
study silymarin administration led to improve the activity 
of SOD and CAT (Figure 1) and increase their antioxidant 
effects which is consistent with a previous study (14). 
Therefore, these effects of silymarin on renal SOD and 
CAT in paraquat-induced nephrotoxicity may be due to 
its antioxidant properties.
Vitamin C is a non-enzymatic antioxidant and can 
protect body against the oxidant agents. There are reports 
of low vitamin C levels in paraquat-induced renal toxicity 
in previous studies (35). Our findings shown a reduction 
of vitamin C levels in paraquat-induced renal toxicity, 
as well (Figure 2). Nevertheless, silymarin could reduce 
the toxic effects of paraquat and consequently increases 
vitamin C levels due to its antioxidant properties. On 
Figure 3. Effects of silymarin on serum TNF-α and expression of TNF-α gene. Values are expressed as mean ± SD and n=8 in each group. Group 
1, normal control; group 2, received paraquat only; group 3, rats supplemented with paraquat and silymarin. 
aP < 0.05 compared to group 1.
bP < 0.05 compared to group 2.
Figure 4. Effects of silymarin on histopathological changes in kidney tissues in rats. A, the normal group (group 1). B, rats treated with paraquat 
only (group2) showing pathological changes in the kidney such as mononuclear cell infiltration. The black arrows show lymphocyte infiltration. C, 
(group 3) paraquat-administered rats supplemented with silymarin (50 mg/kg body weight).
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the other hand, paraquat can induce lipid oxidation and 
protein carbonyl (PC) production through ROS (36,37). 
MDA is considered as a lipid peroxidation biomarker 
(38). In the present study, paraquat administration led 
to increase both the serum and renal MDA and serum 
protein carbonyl levels by producing oxidant agents which 
is consist with previous studies (25,29,35). Silymarin 
administration, however, has reduced serum PC and 
serum and renal MDA levels (Figure 2), which could be an 
indication of silymarin effects on inhibiting the oxidation 
of proteins and lipids, which is consistent with previous 
results (9,39). Also, our results showed that silymarin 
have increased the FRAP level (Table 1), which may be 
due to the silymarin high levels of antioxidant activity, and 
could justify an increase in SOD and CAT activities and a 
decrease in MDA and PC by silymarin. In previous studies, 
an increase in FRAP has been observed by administration 
of silymarin, as well (40).
Oxidative stress can activate the main mediator of 
immunity nuclear factor-kappa β (NF-κβ), which is 
expressed in excessive inflammation and increases pro-
inflammatory cytokines such as TNF-a, IL-1b, IL-6, and 
COX-2. It is reported that production of TNF-α in the 
kidney is responsible for inflammation of the kidney 
through inducing apoptosis pathway and tubular necrosis 
(3,41,42). TNF-α is an inflammatory marker and known 
macrophagic cytokine (43,44). Also, previous studies have 
shown that paraquat-induced renal toxicity is caused by 
oxidative stress and inflammation, and ROS plays a role 
in this toxicity (25). Our findings shown that paraquat 
increased the serum and renal TNF-α gene expression; 
which is consistent with previous study (3). Nevertheless, 
in our study there was a significant decrease in serum and 
TNF-α gene expression in the silymarin treatment group 
(Figure 3). Previous studies have also shown that silymarin 
reduces TNFα in the presence of renal damage (14). Our 
histopathologic tests have shown that silymarin reduces 
infiltration of lymphocytes, apoptosis, and inflammation 
(Figure 4). Silymarin protects the kidneys against 
damage and toxicity through reducing the expression of 
inflammatory factors such as TNF-α.
Conclusion
Silymarin exhibits protective effect against paraquat – 
induced kidney injury. Silymarin increases the level of 
enzymatic (SOD and CAT) and non-enzymatic (Vit C) 
antioxidants in the kidney and reduces the expression 
of inflammatory factors such as TNF-α. Silymarin is 
considered an appropriate antioxidant against oxidative 
stress.
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